3 hours ago
1
Jitendra Jadhav/iStock via Getty Images
- Roche (OTCQX:RHHBY) (OTCQX:RHHBF) said on Thursday that it has received the EU CE mark for its Port Delivery platform, which includes Susvimo, now called Contivue in Europe.
- Susvimo, a ranibizumab injection at a concentration of 100 mg/mL, is currently being reviewed by
English (US) ·